UCB9608 是选择性、可口服的 PI4KIIIβ 抑制剂，IC50=11 nM，对其选择性高于 PI3KC2 α，β 和 γ。它能够增加代谢稳定性，具有良好的药代动力学特征，是一种免疫抑制剂。

UCB9608 is a selective and orally active PI4KIIIβ inhibitor (IC50: 11 nM), selective over PI3KC2 α, β, and γ lipid kinases.

1616413-96-7

C20H26N8O2

410.47

DMSO:60 mg/mL (146.18 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years